Hormone therapy (HT) or hormone replacement therapy (HRT) is recommended for women diagnosed with early menopause in order to replace the hormones the body is missing.

It is recommended to:

• Ease menopausal symptoms
• Maintain bone density and reduce the risk of osteoporosis

In one in 10 women, pregnancy occurs spontaneously after the diagnosis of POF, and where a woman wants to have this chance of spontaneous pregnancy, the hormone therapy consists of continuous oestrogen with cyclic progestin therapy.  Otherwise, a woman can be prescribed the oral contraceptive pill.  Both of these therapies will normally give a monthly period.  If your period doesn’t occur then a pregnancy test should be performed.

Higher doses of hormones are often prescribed because younger women require more hormones to maintain quality of life and wellbeing. Testosterone, which is also a female hormone, may be considered.

Long-term risks of hormone therapy
Although there are no long-term studies of HT in women experiencing an early menopause, it is recommended that HT should be taken to the expected age of menopause (45-50 years of age).  All the studies of long-term use of HT published in recent years have been in women some years after the expected age of menopause, who have much greater risks of heart disease, stroke and cancer because of their age. Anticipated serious adverse effects in younger women are very rare.

Long-term follow up is recommended with your local doctor, specialist or specialist clinic to:

• Monitor your symptoms and therapy
• Maintain regular monitoring of heart disease risks and bone density
• Continue surveillance to exclude the development of other conditions such as other gland failure, thyroid, adrenal, diabetes